MedTrace Logo

Effect of Cervical Multifidus Muscle Area on Interlaminar Epidural Steroid Injection Outcomes

NCT05960487 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-07-25

No results posted yet for this study

Summary

Cervical radiculopathy is one of the most important causes of chronic neck pain. Cervical epidural steroid injections including interlaminar approach are frequently used for treatment option in patients that more conservative modalities are ineffective.

Paraspinal muscles have an important role in supporting neck movements and providing stability of the cervical spine. The multifidus muscle, located in the deepest part of the neck extensor muscle group, has become the muscle that is frequently emphasized in spinal pain in recent years. In the literature, it has been shown that the multifidus muscle on the affected side is atrophied in patients with cervical radiculopathy.

Although many factors are known to be effective on the outcomes of cervical interlaminar epidural injection, there are limited data on the effect of the multifidus muscle area. In this retrospective study, it was planned to investigate the effect of the multifidus muscle area on the results of cervical interlaminar epidural steroid injection.

Conditions

  • Cervical Radiculopathy

Interventions

OTHER

Cervical multifidus muscle area measurement at 3 levels (C4-C5, C5-C6, C6-C7)

Cervical multifidus muscle area measurement will be performed from both the side affected by radiculopathy and the unaffected side using the magnetic resonance (MR) imaging. Measurements will be made by two researchers, independent of each other.

Sponsors & Collaborators

  • Marmara University

    lead OTHER

Principal Investigators

  • Gunay Yolcu, M.D. · Marmara University

  • Osman Hakan Gunduz, Prof. · Marmara University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-20
Primary Completion
2023-08-01
Completion
2023-08-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05960487 on ClinicalTrials.gov